DOI:
10.1055/s-00034612
Yearbook of Medical Informatics
LinksClose Window
References
Gong J, Chehrazi-Raffle A, Reddi S, Salgia R.
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.
J Immunother Cancer 2018;
6 (01) 8
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.